🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
2.970
+0.110 (3.85%)
At close: Nov 20, 2026, 4:00 PM EST
3.005
+0.035 (1.19%)
After-hours: Nov 20, 2026, 7:30 PM EST

Psyence Biomedical Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Selling, General & Admin
4.614.773.321.81.631.72
Research & Development
1.681.470.340.951.610.14
Operating Expenses
6.36.243.662.753.231.86
Operating Income
-6.3-6.24-3.66-2.75-3.23-1.86
Interest Expense
-0.01-0.01-0.01-0.05--
Interest & Investment Income
0.520.260.100-
Earnings From Equity Investments
-0.35-0.05----
Currency Exchange Gain (Loss)
-0-0-0.01-00.03-0
Other Non Operating Income (Expenses)
-0.74-1.330.510.57--
EBT Excluding Unusual Items
-6.88-7.36-3.07-2.23-3.21-1.86
Gain (Loss) on Sale of Investments
-0.430.02---
Other Unusual Items
--4.06-48.93--
Pretax Income
-6.88-6.941.01-51.16-3.21-1.86
Net Income
-6.88-6.941.01-51.16-3.21-1.86
Net Income to Common
-6.88-6.941.01-51.16-3.21-1.86
Net Income Growth
------
Shares Outstanding (Basic)
210---
Shares Outstanding (Diluted)
210---
Shares Change
1931.35%1688.07%----
EPS (Basic)
-2.99-12.5632.76---
EPS (Diluted)
-2.99-12.5632.76---
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-6.51-8.14-3.74-2.95-1.59-1.4
Free Cash Flow Per Share
-2.83-14.74-121.22---
EBITDA
-6.3-6.23-3.66-2.75--
D&A For EBITDA
0.010.0100--
EBIT
-6.3-6.24-3.66-2.75-3.23-1.86
SEC Filings: 10-K · 10-Q